Stephen S. Yoder

2019

In 2019, Stephen S. Yoder earned a total compensation of $1.6M as Chief Executive Officer at Pieris Pharmaceuticals, a 39% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$208,575
Option Awards$815,670
Salary$515,000
Other$54,353
Total$1,593,598

Yoder received $815.7K in option awards, accounting for 51% of the total pay in 2019.

Yoder also received $208.6K in non-equity incentive plan, $515K in salary and $54.4K in other compensation.

Rankings

In 2019, Stephen S. Yoder's compensation ranked 7,035th out of 13,971 executives tracked by ExecPay. In other words, Yoder earned more than 49.6% of executives.

ClassificationRankingPercentile
All
7,035
out of 13,971
50th
Division
Manufacturing
2,697
out of 5,698
53rd
Major group
Chemicals And Allied Products
992
out of 2,197
55th
Industry group
Drugs
841
out of 1,883
55th
Industry
Pharmaceutical Preparations
619
out of 1,395
56th
Source: SEC filing on April 28, 2020.

Yoder's colleagues

We found two more compensation records of executives who worked with Stephen S. Yoder at Pieris Pharmaceuticals in 2019.

2019

Hitto Kaufmann

Pieris Pharmaceuticals

Chief Scientific Officer

2019

Louis Matis

Pieris Pharmaceuticals

Chief Development Officer

News

In-depth

You may also like